Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Trulieve Cannabis Corp. (TRLV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TRLV is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 1 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q2 2026), Trulieve Cannabis Corp. reports quarterly revenue of $271.0M, net income of $-406.1M, free cash flow of $32.1M. TRLV trades on the NYSE exchange and files with the SEC under CIK 1754195. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TRLV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Trulieve Cannabis Corp. directly from SEC EDGAR.
Revenue
$271.0M
Net Income
$-406.1M
Free Cash Flow
$32.1M
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $1.2B | $-116.4M | 12.2% |
| FY 2024 | 10-K | $1.2B | $-155.1M | 8.2% |
| FY 2023 | 10-K | $1.1B | $-526.8M | -19.6% |
| FY 2022 | 10-K | $1.2B | $-252.7M | 4.1% |
| FY 2021 | 10-K/A | $938.4M | $17.4M | 21.0% |
| FY 2020 | 10-K/A | $521.5M | $63.0M | 41.9% |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| SIMPLEX TRADING | 2,300 | $22.6K | 2026-06-30 |
13F Pro Quality Score
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 1 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.